Critical Dietary Factors in Cancer Chemoprevention



de

,

Éditeur :

Springer


Paru le : 2015-10-06



eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
94,94

Téléchargement immédiat
Dès validation de votre commande
Ajouter à ma liste d'envies
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description
This book focuses on the prophylactic potential of diet-derived factors in primary prevention of cancer. It is written by a group of highly reputed experts in the area of dietary agents and cancer chemoprevention. The translational potential of dietary factors from epidemiological, laboratory and clinical studies as prevention strategy in normal and risk populations is highlighted. The work presents options of routine inclusion of specific dietary regimens for prevention as well as therapeutic strategy for better management through adjuvant interventions in cancer treatment.
Pages
373 pages
Collection
n.c
Parution
2015-10-06
Marque
Springer
EAN papier
9783319214603
EAN PDF
9783319214610

Informations sur l'ebook
Nombre pages copiables
3
Nombre pages imprimables
37
Taille du fichier
6031 Ko
Prix
94,94 €
EAN EPUB
9783319214610

Informations sur l'ebook
Nombre pages copiables
3
Nombre pages imprimables
37
Taille du fichier
2140 Ko
Prix
94,94 €

Mohammad Fahad Ullah is Assistant Professor of biochemistry at the Faculty of Applied Medical Sciences and a Research scientist at Prince Fahd Research Centre, University of Tabuk, Saudi Arabia. He received his academic degrees in biochemistry from Aligarh Muslim University, India, followed by studies on cancer cell signaling in cellular & animal models of lung and pancreatic cancer at Experimental Oncology laboratory, Department of Biomedical & Diagnostic Sciences, University of Tennessee, USA. His research interest is in the field of novel plant- or diet-derived chemopreventive compounds and the assessment of their mechanism of action and translational potential. He is member of the editorial / reviewer board of a number of scientific journals. Aamir Ahmad is a Research Scientist at the Wayne State University, Dpt. of Pathology, and Barbara Ann Karmanos Cancer Institute, Detroit, MI. His research interests include elucidating novel targets for therapy in aggressive breast cancers with special focus on key signaling pathways and microRNAs-mediated regulation of metastases and drug-resistance. Dr. Ahmad has authored close to 150 scientific publications and also serves as an academic editor for the journal PLOS One.

Suggestions personnalisées